A Study of IGN002 for Refractory NHL
Clinical trial NCT02847949 · WITHDRAWN
Trial details
- NCT number
- NCT02847949
- Sponsor
- Spectrum Pharmaceuticals, Inc
- Status
- WITHDRAWN
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2021-01-01
- Primary completion
- 2025-07-01
- Enrollment
- 0
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.